Application 202971

Type
NDA
Sponsor
OTSUKA PHARM CO LTD

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001ABILIFY MAINTENA KITARIPIPRAZOLEFOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR300MG/VIALYesNo
002ABILIFY MAINTENA KITARIPIPRAZOLEFOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR400MG/VIALYesYes
003ABILIFY MAINTENA KITARIPIPRAZOLEFOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR300MGYesNo
004ABILIFY MAINTENA KITARIPIPRAZOLEFOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR400MGYesNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
59148-018ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-018ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-018ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-018ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-018ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-019ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-019ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-019ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-019ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-019ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-045ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-045ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-045ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-045ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-045ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-072ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-072ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-072ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-072ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent
59148-072ABILIFY MAINTENAaripiprazoleOtsuka America Pharmaceutical, Inc.NDACurrent

Documents

DocumentSubmission typeDate
81815SUPPL 2026-03-02
84874SUPPL 2026-01-29
84873SUPPL 2026-01-29
82920SUPPL 2025-07-25
82917SUPPL 2025-07-24
81892SUPPL 2025-04-09
81816SUPPL 2025-04-03
81134SUPPL 2025-02-07
80944SUPPL 2025-02-05
61808SUPPL2020-02-06
61793SUPPL2020-02-06
61807SUPPL2020-02-05
49289SUPPL2017-08-08
49180SUPPL2017-08-02
49150SUPPL2017-07-31
47428SUPPL2017-03-02
47323SUPPL2017-02-24
45101SUPPL2016-08-23
45146SUPPL2016-08-18
19404SUPPL2016-01-22
10140SUPPL2016-01-20
40245SUPPL2015-07-30
32344SUPPL2015-07-30
43418SUPPL2015-07-27
19403SUPPL2014-12-10
10139SUPPL2014-12-09
40244SUPPL2014-09-30
40243SUPPL2014-06-03
44872ORIG2013-04-11
22904ORIG2013-04-11
19402ORIG2013-03-15
10138ORIG2013-03-01